Advanced Procedures for Pain Management

[1]  S. Hayek,et al.  Intrathecal Hydromorphone and Bupivacaine Combination Therapy for Post-Laminectomy Syndrome Optimized with Patient-Activated Bolus Device. , 2015, Pain medicine.

[2]  S. Hayek,et al.  Treatment‐Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review of Eight Years of Experience From an Academic Center Database , 2015, Neuromodulation : journal of the International Neuromodulation Society.

[3]  A. Graudins,et al.  Intrathecal Clonidine Pump Failure Causing Acute Withdrawal Syndrome With ‘Stress-Induced’ Cardiomyopathy , 2015, Journal of Medical Toxicology.

[4]  S. Hayek,et al.  Ziconotide Combination Intrathecal Therapy for Noncancer Pain Is Limited Secondary to Delayed Adverse Effects: A Case Series With a 24‐Month Follow‐Up , 2015, Neuromodulation (Malden, Mass.).

[5]  J. Eisenach,et al.  Intrathecal clonidine and adenosine: effects on pain and sensory processing in patients with chronic regional pain syndrome , 2015, Pain.

[6]  D. Kreiner,et al.  The mild® procedure: a systematic review of the current literature. , 2014, Pain medicine.

[7]  T. Deer,et al.  Neuromodulation of Pelvic Visceral Pain: Review of the Literature and Case Series of Potential Novel Targets for Treatment , 2013, Pain practice : the official journal of World Institute of Pain.

[8]  S. Hayek,et al.  Intrathecal Therapy for Chronic Pain: Current Trends and Future Needs , 2013, Current Pain and Headache Reports.

[9]  T. Yaksh,et al.  Pharmacokinetic Analysis of Ziconotide (SNX‐111), an Intrathecal N‐Type Calcium Channel Blocking Analgesic, Delivered by Bolus and Infusion in the Dog , 2012, Neuromodulation : journal of the International Neuromodulation Society.

[10]  B. Jackson,et al.  Sacral nerve stimulation for neuromodulation of the lower urinary tract. , 2012, The Canadian journal of urology.

[11]  Sanghamitra Basu.  Mild Procedure: Single-site Prospective IRB Study , 2012, The Clinical journal of pain.

[12]  Ramsin M. Benyamin,et al.  Long‐Term Results of Percutaneous Lumbar Decompression mild® for Spinal Stenosis , 2012, Pain practice : the official journal of World Institute of Pain.

[13]  K. Valchanov.  Atlas of Implantable Therapies for Pain Management , 2012 .

[14]  R. Al-Hasani,et al.  Molecular mechanisms of opioid receptor-dependent signaling and behavior. , 2011, Anesthesiology.

[15]  N. Mekhail,et al.  SPINE SECTION Original Research Article Combination of Intrathecal Opioids with Bupivacaine Attenuates Opioid Dose Escalation in Chronic Noncancer Pain Patients , 2016 .

[16]  B. Chopko,et al.  mild® Lumbar Decompression for the Treatment of Lumbar Spinal Stenosis , 2011, The neuroradiology journal.

[17]  C. Gómez,et al.  Sacral nerve stimulation for fecal incontinence. , 2011, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[18]  A. Yakovlev,et al.  Sacral Nerve Stimulation: A Novel Treatment of Chronic Anal Fissure , 2011, Diseases of the colon and rectum.

[19]  B. Chopko.  A novel method for treatment of lumbar spinal stenosis in high-risk surgical candidates: pilot study experience with percutaneous remodeling of ligamentum flavum and lamina. , 2011, Journal of neurosurgery. Spine.

[20]  J. Grider,et al.  Retrospective review of patient self-reported improvement and post-procedure findings for mild (minimally invasive lumbar decompression). , 2010, Pain physician.

[21]  E. Baird.  Obstetric Anesthesia Handbook , 2010 .

[22]  D. Caraway,et al.  MiDAS I (mild Decompression Alternative to Open Surgery): a preliminary report of a prospective, multi-center clinical study. , 2010, Pain physician.

[23]  J. Abbas,et al.  Ligamentum Flavum Thickness in Normal and Stenotic Lumbar Spines , 2010, Spine.

[24]  T. Deer,et al.  New image-guided ultra-minimally invasive lumbar decompression method: the mild procedure. , 2010, Pain physician.

[25]  R. Dong,et al.  Intrathecal administration of clonidine attenuates spinal neuroimmune activation in a rat model of neuropathic pain with existing hyperalgesia. , 2009, European journal of pharmacology.

[26]  R. Rauck,et al.  An Open‐Label, Multicenter Study of the Safety and Efficacy of Intrathecal Ziconotide for Severe Chronic Pain When Delivered via an External Pump , 2008, Neuromodulation : journal of the International Neuromodulation Society.

[27]  P. Staats,et al.  The Use of Implanted Programmable Infusion Pumps in the Management of Nonmalignant, Chronic Low‐Back Pain , 2007, Neuromodulation : journal of the International Neuromodulation Society.

[28]  M. Backonja,et al.  Depression, Night Terrors, and Insomnia Associated With Long‐Term Intrathecal Clonidine Therapy , 2007, Pain practice : the official journal of World Institute of Pain.

[29]  J. McGivern.  Ziconotide: a review of its pharmacology and use in the treatment of pain , 2007, Neuropsychiatric disease and treatment.

[30]  N. Mekhail,et al.  Redefining reflex sympathetic dystrophy and causalgia , 2004 .

[31]  N. Mekhail,et al.  Pharmacology of intrathecally administered agents for treatment of spasticity and pain , 2003 .

[32]  R. Rosenquist,et al.  Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. , 2003, Journal of pain and symptom management.

[33]  M. Drass,et al.  Pharmacokinetics and Pharmacodynamics of Intrathecal Ziconotide in Chronic Pain Patients , 2003, Journal of clinical pharmacology.

[34]  C. Bernards.  Understanding the physiology and pharmacology of epidural and intrathecal opioids. , 2002, Best practice & research. Clinical anaesthesiology.

[35]  Y. E. Mironer,et al.  Efficacy and Safety of Intrathecal Opioid/Bupivacaine Mixture in Chronic Nonmalignant Pain: A Double Blind, Randomized, Crossover, Multicenter Study by the National Forum of Independent Pain Clinicians (NFIPC) , 2002, Neuromodulation : journal of the International Neuromodulation Society.

[36]  D. Caraway,et al.  Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine. , 2002, The spine journal : official journal of the North American Spine Society.

[37]  S. Hassenbusch,et al.  Intrathecal clonidine in the treatment of intractable pain: a phase I/II study. , 2002, Pain medicine.

[38]  C. Bernards,et al.  Comparative Spinal Distribution and Clearance Kinetics of Intrathecally Administered Morphine, Fentanyl, Alfentanil, and Sufentanil , 2000, Anesthesiology.

[39]  K. Aló,et al.  Lumbar and Sacral Nerve Root Stimulation (NRS) in the Treatment of Chronic Pain: A Novel Anatomic Approach and Neuro Stimulation Technique , 1999, Neuromodulation : journal of the International Neuromodulation Society.

[40]  W. Catterall,et al.  Localization of Ca2+ Channel Subtypes on Rat Spinal Motor Neurons, Interneurons, and Nerve Terminals , 1998, The Journal of Neuroscience.

[41]  D M Simpson,et al.  Traditional pharmacological treatments for spasticity part II: General and regional treatments , 1997, Muscle & nerve. Supplement.

[42]  H. Miranda,et al.  α‐Adrenoceptor and opioid receptor modulation of clonidine‐induced antinociception , 1996, British journal of pharmacology.

[43]  M. A. Rowe,et al.  Differential Nerve Block: Direct Measurements on Individual Myelinated and Unmyelinated Dorsal Root Axons , 1996, Anesthesiology.

[44]  A. Namiki.  Handbook of Spinal Anesthesia and Analgesia , 1995 .

[45]  M. A. Rowe,et al.  Subanesthetic concentrations of lidocaine selectively inhibit a nociceptive response in the isolated rat spinal cord , 1995, Pain.

[46]  T. Naruse,et al.  Relationship between hypotensive effects and plasma concentrations of clonidine in spontaneously hypertensive rats: continuous treatment and sudden termination of clonidine infusion. , 1994, General Pharmacology.

[47]  R. Penn,et al.  The distribution of medication along the spinal canal after chronic intrathecal administration. , 1993, Neurosurgery.

[48]  S. A. Raymond.  Subblocking Concentrations of Local Anesthetics: Effects on Impulse Generation and Conduction in Single Myelinated Sciatic Nerve Axons in Frog , 1992, Anesthesia and analgesia.

[49]  M. Boswell,et al.  Sites of Action of Subarachnoid Lidocaine and Tetracaine: Observations with Evoked Potential Monitoring during Spinal Cord Stimulator Implantation , 1991, Regional anesthesia and pain medicine.

[50]  B. R. Fink,et al.  Mechanisms of Differential Axial Blockade in Epidural and Subarachnoid Anesthesia , 1989, Anesthesiology.

[51]  A. Burm,et al.  Clinical Pharmacokinetics of Epidural and Spinal Anaesthesia , 1989, Clinical pharmacokinetics.

[52]  Y. Shir.  Intrathecal Opioids, Potency and Lipophilicity. , 1989, Pain.

[53]  R. Penn,et al.  CONTINUOUS INTRATHECAL BACLOFEN FOR SEVERE SPASTICITY , 1985, The Lancet.

[54]  I. Creese,et al.  Opiate receptor binding affected differentially by opiates and opioid peptides. , 1979, European journal of pharmacology.

[55]  F. Magora,et al.  EPIDURAL MORPHINE IN TREATMENT OF PAIN , 1979, The Lancet.

[56]  John E. Thomas,et al.  Pain relief by intrathecally applied morphine in man. , 1979, Anesthesiology.

[57]  S. Snyder,et al.  Guanine nucleotides differentiate agonist and antagonist interactions with opiate receptors. , 1978, Life Science.

[58]  H. Fields,et al.  Opiate and stimulus-produced analgesia: functional anatomy of a medullospinal pathway. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[59]  T. Yaksh,et al.  Analgesia mediated by a direct spinal action of narcotics. , 1976, Science.